David S. Ege - Executive Vice President and Chief Technology Officer at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Vice President and Chief Technology Officer
Stock Symbol
MCRB on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

David S. Ege - trading volume in the past year for Seres Therapeutics, Inc.

Holdings reported by David S. Ege for Seres Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 75.7 K $71.2 K $0.94 May 15, 2024 Direct
Restricted Stock Units 32.7 K $30.7 K $0.94 May 15, 2024 Direct Common Stock
Stock Option (Right to Buy) 288 K Feb 14, 2024 Direct Common Stock

Transactions reported by David S. Ege for Seres Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership